Genetic susceptibility to dioxin-like chemicals' induction of cytochrome P4501A2 in the human adult linked to specific AhRR polymorphism

Chemosphere

Volumn 90, Issue 9, 2013, Pages 2358-2364

  Hung, Wan Ting ^a   Lambert, George H ^b   Huang, Ping Wei ^c   Patterson, Donald G ^d   Guo, Yue Leon ^a,c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d EnviroSolutions Consulting Inc   (United States)

Author keywords

Aryl hydrocarbon receptor; Aryl hydrocarbon receptor repressor; CYP1A2 activity and induction; Dioxin like chemicals; PCBs and PCDFs; Single nucleotide polymorphisms

Indexed keywords

BIOMARKERS; BLOOD; CHEMICALS; HYDROCARBONS; NUCLEOTIDES; POLYCHLORINATED BIPHENYLS; POLYMORPHISM; TRANSCRIPTION;

ARYL HYDROCARBON RECEPTOR; CYP1A2 ACTIVITY AND INDUCTION; DIOXIN LIKES; GENETIC POLYMORPHISMS; GENETIC SUSCEPTIBILITY; HUMAN HEALTH EFFECTS; SERUM CONCENTRATION; SINGLE NUCLEOTIDE POLYMORPHISMS;

ORGANIC POLLUTANTS;

AROMATIC HYDROCARBON RECEPTOR; AROMATIC HYDROCARBON RECEPTOR REPRESSOR; CAFFEINE; CYTOCHROME P450 1A2; DIOXIN; UNCLASSIFIED DRUG;

ADULT; BIOMARKER; BLOOD; CHEMICAL BINDING; CYTOCHROME; DIOXIN; GENETIC VARIATION; HEALTH RISK; POLYMORPHISM; PUBLIC HEALTH; SERUM;

ADULT; ARTICLE; BREATH ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; SINGLE NUCLEOTIDE POLYMORPHISM;

CHINA; SHANDONG; YUCHENG;

EID: 84872826003     PISSN: 00456535     EISSN: 18791298     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2012.10.026     Document Type: Article

References (41)

1. Abel J., Haarmann-Stemmann T. An introduction to the molecular basics of aryl hydrocarbon receptor biology. Biol. Chem. 2010, 391:1235-1248.
2. Anttila S., Lei X.D., Elovaara E., Karjalainen A., Sun W., Vainio H., et al. An uncommon phenotype of poor inducibility of CYP1A1 in human lung is not ascribable to polymorphisms in the AHR, ARNT, or CYP1A1 genes. Pharmacogenetics 2000, 10:741-751.
3. Asada H., Yagihashi T., Furuya M., Kosaki K., Takahashi T., Yoshimura Y. Association between patient age at the time of surgical treatment for endometriosis and aryl hydrocarbon receptor repressor polymorphism. Fertil. Steril. 2009, 92:1240-1242.
4. Baba T., Shima Y., Owaki A., Mimura J., Oshima M., Fujii-Kuriyama Y., et al. Disruption of aryl hydrocarbon receptor (AhR) induces regression of the seminal vesicle in aged male mice. Sex. Dev. 2008, 2:1-11.
5. Bruner-Tran K.L., Yeaman G.R., Crispens M.A., Igarashi T.M., Osteen K.G. Dioxin may promote inflammation-related development of endometriosis. Fertil. Steril. 2008, 89:1287-1298.
6. Carpenter, D.O., 2006. Polychlorinated biphenyls (PCBs): routes of exposure and effects on human health. Rev. Environ. Health 21, 1-24.x.
7. Cauchi S., Stücker I., Solas C., Laurent-Puig P., Cénée S., Hémon D., et al. Polymorphisms of human aryl hydrocarbon receptor (AhR) gene in a French population: relationship with CYP1A1 inducibility and lung cancer. Carcinogenesis 2001, 22:1819-1824.
8. Das S.K., Sharma N.K., Chu W.S., Wang H., Elbein S.C. Aryl hydrocarbon receptor nuclear translocator (ARNT) gene as a positional and functional candidate for type 2 diabetes and prediabetic intermediate traits: mutation detection, case-control studies, and gene expression analysis. BMC Med. Genet. 2008, 9:16.
9. Evans B.R., Karchner S.I., Franks D.G., Hahn M.E. Duplicate aryl hydrocarbon receptor repressor genes (ahrr1 and ahrr2) in the zebrafish Danio rerio: structure, function, evolution, and AHR-dependent regulation in vivo. Arch. Biochem. Biophys. 2005, 441:151-167.
10. Evans B.R., Karchner S.I., Allan L.L., Pollenz R.S., Tanguay R.L., Jenny M.J., et al. Repression of aryl hydrocarbon receptor (AHR) signaling by AHR repressor: role of DNA binding and competition for AHR nuclear translocator. Mol. Pharmacol. 2008, 73:387-398.
11. Figueroa J.D., Malats N., García-Closas M., Real F.X., Silverman D., Kogevinas M., et al. Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes. Carcinogenesis 2008, 29:1955-1962.
12. Fujita H., Kosaki R., Yoshihashi H., Ogata T., Tomita M., Hasegawa T., et al. Characterization of the aryl hydrocarbon receptor repressor gene and association of its Pro185Ala polymorphism with micropenis. Teratology 2002, 65:10-18.
13. Guo Y.L., Yu M.L. The Yucheng rice oil poisoning incident. Dioxins and Health 2003, Wiley, New York, pp. 893-913 (Chapter 22). A. Schecter (Ed.).
14. Guo Y.L., Ryan J.J., Lau B.P.Y., Yu M.L., Hsu C.C. Serum levels of PCB/PCDF congeners 14years after accidental exposure to contaminated rice oil. Arch Environ. Contam. Toxicol. 1997, 33:104-108.
15. Hahn M.E., Allan L.L., Sherr D.H. Regulation of constitutive and inducible AHR signaling: complex interactions involving the AHR repressor. Biochem. Pharmacol. 2009, 77:485-497.
16. Harper P.A., Wong J.M.Y., Lam M.S.M., Okey A.B. Polymorphisms in the human AH receptor. Chem. Biol. Interact. 2002, 141:161-187.
17. International HapMap Consortium, 2003. International HapMap Project. (accessed 02.02.11). http://hapmap.ncbi.nlm.nih.gov/index.html.en.
18. Jensen A.A. Polychlorinated biphenyls (PCBs), polychlorodibenzo-p-dioxins (PCDDs) and polychlorodibenzofurans (PCDFs) in human milk, blood, and adipose tissue. Sci. Total Environ. 1987, 64:259-293.
19. 185 variants repress both AHR and Hypoxia-Inducible Factor. Mol. Cell. Biol. 2009, 29:3465-3477.
20. Kawajiri K., Watanabe J., Eguchi H., Nakachi K., Kiyohara C., Hayashi S. Polymorphisms of human Ah receptor gene are not involved in lung cancer. Pharmacogenet. Genomics 1995, 5:151-158.
21. Kayano S., Suzuki Y., Kanno K., Aoki Y., Kure S., Yamada A., et al. Significant association between nonsyndromic oral clefts and arylhydrocarbon receptor nuclear translocator (ARNT). Am. J. Med. Genet. A 2004, 130A:40-44.
22. Kimbrough R.D. Laboratory and human studies on polychlorinated biphenyls (PCBs) and related compounds. Environ. Health Prospect. 1985, 59:99-106.
23. Lambert G.H., Needham L.L., Turner W., Lai T.J., Patterson D.G., Guo Y.L. Induced CYP1A2 activity as a phenotypic biomarker in humans highly exposed to certain PCBs/PCDFs. Environ. Sci. Technol. 2006, 40:6176-6180.
24. Merisalu A., Punab M., Altmäe S., Haller K., Tiido T., Peters M., et al. The contribution of genetic variations of aryl hydrocarbon receptor pathway genes to male factor infertility. Fertil. Steril. 2007, 88:854-859.
25. National Institute of Environmental Health Sciences (NIEHS) SNPs. NIEHS Environmental Genome Project, University of Washington, Seattle, WA. (accessed 02.02.11). http://egp.gs.washington.edu/welcome.html.
26. Nukaya M., Bradfield C.A. Conserved genomic structure of the Cyp1a1 and Cyp1a2 loci and their dioxin responsive elements cluster. Biochem. Pharmacol. 2009, 77:654-659.
27. Pascual G., Glass C.K. Nuclear receptors versus inflammation: mechanisms of transrepression. Trends Endocrinol. Metab. 2006, 17:321-327.
28. Pelkonen O., Turpeinen M., Hakkola J., Honkakoski P., Hukkanen J., Raunio H. Inhibition and induction of human cytochrome P450 enzymes: current status. Arch. Toxicol. 2008, 82:667-715.
29. Rowlands J.C., Gustafsson J. Aryl hydrocarbon receptor-mediated signal transduction. Crit. Rev. Toxicol. 1997, 27:109-134.
30. Schweikl H., Taylor J.A., Kitareewan S., Linko P., Nagorney D., Goldstein J.A. Expression of CYP1A1 and CYP1A2 genes in human liver. Pharmacogenetics 1993, 3:239-249.
31. Simsa P., Mihalyl A., Schoeters G., Koppen G., Kyamaa C.M., Den Hond E.M., et al. Increased exposure to dioxin-like compounds is associated with endometriosis in a case-control study in women. Reprod. Biomed. 2010, 20:681-688.
32. Smart J., Daly A.K. Variation in induced CYP1A1 levels: relationship to CYP1A1, Ah receptor and GSTM1 polymorphisms. Pharmacogenetics 2000, 10:11-24.
33. Smith G.B., Harper P.A., Wong J.M., Lam M.S., Reld K.R., Petsikas D., et al. Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms. Cancer Epidemiol. Biomarkers. Prev. 2001, 10:839-853.
34. Soneda S., Fukami M., Fujimoto M., Hasegawa T., Koitabashi Y., Ogata T. Association of micropenis with Pro185Ala polymorphism of the gene for aryl hydrocarbon receptor repressor involved in dioxin signaling. Endocr. J. 2005, 52:83-88.
35. Srogi K. Levels and congener distributions of PCDDs, PCDFs and dioxin-like PCBs in environmental and human samples: a review. Environ. Chem. Lett. 2008, 6:1-28.
36. Tsuchiya M., Katoh T., Motoyama H., Sasaki H., Tsugane S., Ikenoue T. Analysis of the AhR, ARNT, and AhRR gene polymorphisms: genetic contribution to endometriosis susceptibility and severity. Fertil. Steril. 2005, 84:454-458.
37. Van den Berg M., Birnbaum L., Bosveld A.T., Brunstrom B., Cook P., Feeley M., et al. Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ. Health Perspect. 1998, 106:775-792.
38. Van den Berg M., Birnbaum L., Denison M., DeVito M., Farland W., Feeley M., et al. The 2005 world health organization reevaluation of human and mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicol. Sci. 2006, 93:223-241.
39. Watanabe T., Imoto I., Kosugi Y., Fukuda Y., Mimura J., Fujii Y., et al. Human arylhydrocarbon receptor repressor (AHRR) gene: genomic structure and analysis of polymorphism in endometriosis. J. Hum. Genet. 2001, 46:342-346.
40. Watanabe M., Sueoka K., Sasagawa I., Nakabayashi A., Yoshimura Y., Ogata T. Association of male infertility with Pro185Ala polymorphism in the aryl hydrocarbon receptor repressor gene: implication for the susceptibility to dioxins. Fertil. Steril. 2004, 82(Suppl 3):1067-1071.
41. Zhou S.F., Wang B., Yang L.P., Liu J.P. Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2. Drug Metab. Rev. 2010, 42:268-354.